Therefore, to develop an effective strategy for overcoming CCRT resistance, it is critical to elucidate the mechanism by which SOX17 dysregulation leads to CCRT resistance in ESCC patients. The gene discussed is SOX17; the disease is esophageal squamous cell carcinoma.